![Johannes Woehrstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Johannes B.
Woehrstein is the founder and current Chief Technology Officer of Mbiomics GmbH, which is founded in 2020.
Posizioni attive di Johannes Woehrstein
Società | Posizione | Inizio |
---|---|---|
Mbiomics GmbH
![]() Mbiomics GmbH Miscellaneous Commercial ServicesCommercial Services Mbiomics GmbH is a German company that specializes in microbiome analysis. The company is based in Munich, Germany. The company's patented precision technology allows for fast, quantitative, and accurate analysis of the microbiome, which creates a basis for various future clinical applications and accelerates microbiome-based therapeutics development. Mbiomics offers high-resolution measurements of the composition of the microbiome, combining DNA and RNA analysis with a highly standardized workflow and unique single/molecule detection to tackle the three key challenges in microbiome profiling. The company was founded in 2020 by Laura Figulla, Johannes B. Woehrstein, Heinrich Grabmayr, and Laura Figulla has been the CEO since 2020. | Fondatore | 01/01/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Mbiomics GmbH
![]() Mbiomics GmbH Miscellaneous Commercial ServicesCommercial Services Mbiomics GmbH is a German company that specializes in microbiome analysis. The company is based in Munich, Germany. The company's patented precision technology allows for fast, quantitative, and accurate analysis of the microbiome, which creates a basis for various future clinical applications and accelerates microbiome-based therapeutics development. Mbiomics offers high-resolution measurements of the composition of the microbiome, combining DNA and RNA analysis with a highly standardized workflow and unique single/molecule detection to tackle the three key challenges in microbiome profiling. The company was founded in 2020 by Laura Figulla, Johannes B. Woehrstein, Heinrich Grabmayr, and Laura Figulla has been the CEO since 2020. | Commercial Services |
- Borsa valori
- Insiders
- Johannes Woehrstein